Abstract
Torque teno virus (TTV) is highly prevalent, but little is known about its circulation in humans. Here, we investigated the geographical distribution and phylogeny of TTV in Romania. A fragment of TTV untranslated region B was sequenced in samples from volunteers across the country. Additional sequences from dialyzed patients were also included in the study. Phylogenetic analysis showed that more than 80% of Romanian sequences clustered with isolates assigned to the species Torque teno virus 1 and Torque teno virus 3 (former genogroup 1), and this analysis discriminated between isolates from the North-East and West regions. Further studies assessing the pathogenic potential of TTV isolates should employ analysis based on genomic regions with phylogenetic resolution below the species level.
Avoid common mistakes on your manuscript.
Torque teno virus (TTV) is a small non-enveloped virus with a single-stranded circular DNA genome that primarily infects humans. It belongs to the genus Alphatorquevirus within the family Anelloviridae [1, 2]. Its genome contains an untranslated region (UTR, divided into UTR A and UTR B) [3] and a coding region with three to four open reading frames. Of the two regions, the UTR is more conserved, and it has been hypothesized that it may play an important role in viral replication [4]. The high genetic variability of TTV previously led to its classification into seven genogroups [5,6,7], which were subdivided into multiple genotypes [6, 8]. The current taxonomy of the family Anelloviridae is based on analysis of entire ORF1 sequence and imposes the following cutoff values for sequence divergence: genera >56%, species >35%, subspecies >20%, and isolates <20% [9, 10]. According to the latest ICTV Master Species List, the genus Alphatorquevirus includes 26 species (Torque teno virus 1-31 and four species whose members infect non-human primates) [10].
Despite the extremely high prevalence of TTV, searches for association with disease have not yielded any significant results. Genotype-specific pathogenicity has also been considered; for instance, isolates similar to TA278 TTV1 (former genotype 1) were associated with hepatitis of unknown etiology and increased ALT levels [1], as well as head and neck carcinoma [11]. Isolate-specific pathogenicity remains debatable, as there is no strong evidence to support or to reject this hypothesis.
Although TTV does not seem to be pathogenic per se, its capacity to modulate and evade immune response [12, 13] may predispose infected individuals to multiple autoimmune diseases [14] or augment pre-existing condition(s). In the last few years, attention shifted from the pathogenic potential of TTV to its potential use as a biomarker. There is strong evidence supporting the use of TTV DNA-aemia as biomarker for monitoring the kinetics of functional immune competence before and after solid organ transplantation [15,16,17], monitoring the efficacy of antiviral treatments in HIV-infected patients [18], or even predicting clinical outcome in SARS-CoV-2-infected patients [19]. However, discriminating between TTV isolates that may be associated with pathology and innocuous isolates should not be overlooked, and genotyping and tracking their distribution thus remain an important task.
Despite several studies investigating the prevalence of TTV in Romania and its association with pathology [20,21,22], information on the molecular characteristics and phylogeny of these viruses is still limited in this country.
The aim of this study was to determine the prevalence and geographical distribution of TTV in Romania and to describe the phylogenetic relationships between isolates found in healthy Romanian subjects, as well as in hemodialyzed patients.
Two hundred thirty-six clinically healthy volunteers undergoing a routine medical check-up (110 males and 126 females) were selected between April and May 2019 from Romania’s major healthcare centers (Table 1). Three of the individuals were immigrants from Europe, the Middle East, and the Far East, respectively. Blood samples were collected after informed consent was signed. The study was approved by the National Institute of Research and Development for Food Bioresources Ethics Committee with the registration number 342/16.05.2014. Consent forms for underage subjects were signed by legal guardians. Samples were given codes, and analysis was performed in a blind manner. Only information on age, gender, and residence was available.
Briefly, genomic DNA was purified from whole blood using a commercial kit (PureLink® Genomic DNA Mini Kit, Invitrogen) and was used for PCR amplification of a fragment of UTR B using primers described previously [3]. Gel-purified amplicons (PureLink® PCR Purification Kit, Invitrogen) were quantified using a Qubit fluorometer (dsDNA HS Assay Kit, Invitrogen) and subjected to direct sequencing using a BigDye™ Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) on a 3130 Genetic Analyzer (Applied Biosystems).
Chi-squared and Fisher's exact test were used to examine possible differences in the prevalence of TTV DNA between males and females, while the independent-samples Mann-Whitney U test was used to compare means. Statistical analysis was conducted using SPSS Statistics software v 20.0.0 (IBM).
The subjects selected for the study were residents of all eight development regions of Romania (NUTS 2 regions): the Bucharest metropolitan area (Bucharest and Ilfov County), South, South-East, North-East, Center, North-West, West, and South-West development regions. The place of residence of the study participants is presented in Fig. 1.
Of the 236 subjects analyzed, 156 (66%) were positive for TTV DNA. There was no difference between the distribution of TTV DNA in males and females (chi-squared p > 0.05). A statistically significant difference in the distribution of TTV DNA in different age groups (independent-samples Mann-Whitney U test p = 0.002) was identified, where prevalence increased with age. The geographical distribution of TTV DNA prevalence did not differ significantly and ranged between 54.5% (12/22) in the South-West region and 85.7% (6/7) in the West region.
The TTV prevalence recorded in our study group was lower than those reported for the general population of other European countries (e.g., 84-88% in Italy, Finland, Poland, and Greece [23]) and Asian countries (e.g., 72% in India [24], 83.4% in Qatar [25], and 93.3% in China [26]) but higher than the TTV prevalence reported for Iran (49.3%) in 2018 [27]. However, these variations might have been due to the genomic target used for TTV detection. Also, as TTV DNA prevalence and viral load have been shown to increase with age [20, 23], our results may be explained by the age of subjects tested in different studies. The genomic region amplified in our study is generally highly conserved and enables the detection of many different TTV variants. However, isolates of TTV9, TTV10, TTV25, TTV26, and TTV29 (all members of the former genogroups 4 and 5) have a low detection rate using this primer set.
Of the TTV-positive samples, 80 random samples (20 from Bucharest, five from the Center region, seven from North-East, two from North-West, 18 from South, 15 from South-East, eight from South-West, four from West and one non-Romanian sample) were subjected to direct amplicon sequencing. More than half (43/80, 54%) of the positive samples generated electropherograms with overlapping peaks and correct base spacing, suggesting the presence of multiple TTV variants within the same individual. Those sequences were not included in the phylogenetic analysis. Mixed infections with viruses belonging to the same or different genera of the family Anelloviridae – in both healthy individuals and patients with various medical conditions – are frequently reported and are a characteristic of the members of this family [5, 20, 25, 28,29,30].
The sequences obtained from subjects with monotypic infections (n = 37) were submitted to the European Nucleotide Archive (ENA) of EMBL under the accession numbers LR742476-85, LR742487-512, and OU989706. In order to maintain the resolution of the phylogenetic analysis, four of these sequences (shorter than 200 bp) were excluded from further analysis. In addition to these samples, 12 other sequences obtained previously from obese Romanian patients with diabetic nephropathy who were undergoing hemodialysis were included. Also, two positive control samples from a subject known to have TTV infection, collected in 2015 (LB809941) and 2019 (LR742486), were included in the analysis (Fig. 2).
Phylogenetic analysis was conducted by the maximum-likelihood method with the Kimura 2-parameter model and 1000 bootstrap replicates, using MEGA X software [31]. The model for estimating genetic distance was chosen using MEGA X. Information on isolates used for constructing the phylogenetic tree is found in Supplementary Material.
The sequences obtained in this study were relatively distant from most of the reference strain sequences for species identification. In order to obtain a high-resolution phylogenetic tree, only the sequences displaying a high percentage of identity to the sequences obtained in this study were included in the analysis.
The phylogenetic tree (Fig. 2) clearly depicts the relationships between the sequences obtained from Romanian subjects, as well as the relationships between these sequences and others assigned or unassigned to worldwide TTV isolates. The analyzed sequences grouped into six clades (designated A to F) supported by bootstrap values greater than 80%.
Clade A contained sequences highly similar to those of isolates belonging to the species Torque teno virus 3, such as the Polish isolate P/1C1, as well as unassigned sequences from Malaysian patients infected with hepatitis viruses, while clades E and F clustered with sequences similar to those of isolates belonging to the species Torque teno virus 1, such as American isolate US32 and French isolate T3PB. Romanian isolates with sequences similar to that of the Finnish isolate TTV3-HEL32 formed clade D. In the former genogroup classification of TTV, isolates US32, T3PB, and HEL32 belonged to genotype 2 [32], genotype 3 [33], and genotype 6 [34], respectively, of genogroup 1. The majority of the Romanian sequences (41/47, 87%) clustered in these four clades (A, D, E, and F).
Clade B comprised one Romanian sequence from a dialyzed patient, TTV31-Hebei-1 isolate – originating from a Chinese patient with fatal fever [7] – and the unassigned isolate TTVMY HB34 from a Malaysian hepatitis B patient (unpublished results). TTV31-Hebei-1 is an established member of the genus Alphatorquevirus [10] and, according to the former classification, belonged to genogroup 7 [5]; the Romanian isolate (RO-od21) may belong to the same species.
Clade C consisted of Romanian sequences and an unassigned Malaysian isolate. The closest sequences to clade C that were not included in the clade were TTV19-SANBAN and a member of the species Torque teno virus 24 (svi-1).
The genomic region analyzed in this study, as well as in another recent study [35], proves to have a higher phylogenetic resolution, as it is able to discriminate between TTV subspecies, defined as a grouping of isolates with ORF1 nucleotide sequence divergence of 35-20% [9]).
The first protocols used for TTV phylogenetic analysis were based on N22 PCR, which amplifies mostly isolates belonging to the species Torque teno virus 1-5 (former genogroup 1) [36], and thus data regarding the phylogenetic distribution of TTV in different populations are scarce and limited to studies from Italy and South America (Brazil and Uruguay). A study describing the phylogenetic relationships between TTV isolates from Iranian hepatitis patients [27] highlights the importance of choosing genomic regions with good phylogenetic resolution, because the tree obtained in the above-mentioned study lacks support (bootstrap values for major branches below 10) and leads to artificial grouping or dividing of known highly dissimilar or similar isolates into clusters.
Studies performed in Italy [37], Brazil [38], Uruguay [39], and Japan [40] showed TTV genogroup 3 to be the most prevalent, followed closely by genogroup 1, while the least prevalent was genogroup 2. Studies from Brazil found genogroup 5 isolates to be the most frequent [29, 41]. Most Romanian sequences obtained in this study exhibited high similarity to TTV1 and TTV3 isolates, formerly belonging to genogroup 1 (41/47, 87%). Some of the Romanian sequences were closer to TTV19 and TTV24 – formerly belonging to genogroup 3 (5/47, 11%). None of the sequences obtained resembled isolates of TTV6-7 (genogroup 2), TTV25-26, TTV29 (genogroup 4), or TTV9-10 (genogroup 5) (data not shown). Nevertheless, one of the disadvantages of using UTR B primers is the low detection rate of TTV9, TTV10, TTV25, TTV26, and TTV29 isolates (from former genogroups 4 and 5).
Analysis performed in different countries (Hungary [11, 30], Czech Republic [42], Egypt [43], Saudi Arabia [44], India [45], Japan, Korea, Shanghai, Mongolia, Colombia, Cameroon, Germany, and UK [46]) revealed TTV1 isolates similar to TA278 and US32 (former genotypes 1 and 2) to be the most prevalent and widespread in populations worldwide. Other studies showed evidence that TTV3 isolate HEL32 (former genotype 6) was found mainly among Asians, while isolate TTV1 isolate T3PB (former genotype 3) was found mainly among Europeans [46]. Sixteen sequences (34%) obtained in our study clustered with isolate T3PB, supporting these last reports.
Migration rates have been shown to alter the epidemiology of viral infections (e.g., HCV genotype circulation in Turkey [47], dispersal of HIV from Uganda [48]). In the present context of global migration – mainly due to the refugee crisis, Romania was not a preferred destination for Asian immigrants. Moreover, the Migration Policy Institute (https://www.migrationpolicy.org/programs/data-hub/charts/immigrant-and-emigrant-populations-country-origin-and-destination) and Eurostat (https://ec.europa.eu/eurostat/databrowser/view/tps00177/default/map?lang=en) data show that most immigrants in Romania come from the neighboring countries and that the efflux of the Romanian population is higher than the influx. Considering these aspects, the particular distribution of TTV in Romania could be explained by low immigration rates.
Sequences obtained from samples collected in Bucharest were found in all clades, except for B and D. Bucharest is the capital city of Romania, with almost 2,000,000 permanent inhabitants, and is the largest university center and employer in the country. Many of its inhabitants come from all over the country, thus explaining the diversity observed in the current study for the Bucharest metropolitan area.
All sequences from the North-East region (indicated by yellow squares in Fig. 2) were found in clade A, together with TTV3 isolates P/1C1 and tth16, as well as two unassigned isolates from Malaysia (i.e., TTVMY HC9, from the serum of a control subject, and TTVMY HB25, from the serum of an HBV-infected patient). Sequences obtained from samples collected from the West and Center of the country (indicated by blue and pink squares in Fig. 2) were aggregated in clade F, together with an unassigned isolate from Malaysia (TTVMYC124) and TTV1 isolate T3PB. The separation of sequences originating in subjects living in the North-East and West regions of Romania in distinct clades may be explained by a geographical barrier – the Carpathian Mountains – limiting the population exchange between these areas. However, in order to test this hypothesis, more sequences from subjects residing in the Center and the West regions should be added to the analysis.
Of the samples collected from immigrants, two out of three were TTV positive. The sequences obtained from the positive samples were, however, of insufficient quality for further analysis.
The sequences obtained from the subject with TTV infection in 2015 (LN809941) and 2019 (LR742486) grouped separately. The sequence obtained in 2015 aggregated together with the TTV1 US32 isolate, while the sequence obtained four years later shared the highest degree of similarity with an unassigned isolate derived from an HBV-infected Malaysian (TTVMY HB25) and grouped closer with isolates currently belonging to TTV3. This result suggests that periodic clearing of TTV and acquisition of a different strain can occur. Another explanation takes into consideration the fact that mixed TTV infections occur [5, 20, 25, 28,29,30] and that the viral dynamics can change over time [49]. Thus, at a single point in time, a certain strain may have a higher viral load and become the only one detected using the selected amplification strategy or Sanger sequencing.
Sequences derived from dialyzed obese patients with diabetic nephropathy were found scattered in almost all clades (Fig. 2). However, almost half of these sequences (5/12) grouped together with TTV3 (isolate HEL32, former genotype 6) and TTV19 (SANBAN). TTV3 isolate HEL32 has an overall low prevalence [50] and is more likely to be found in hepatitis patients [30, 43]. TTV19 isolate SANBAN was shown to produce a protein suppressing the NF-κB pathway, contributing to TTV pathogenicity and relating it to autoimmune and/or inflammation-prone conditions [51].
The most common TTV isolates among healthy Romanian individuals were similar to TTV1 and TTV3 isolates (former genogroup 1). There seems to be a geographical distribution of TTV isolates from east to west in the country, while in the metropolitan area of the capital and neighboring counties, the circulation of TTV isolates has no apparent boundaries. It is possible that TTV from the most prevalent species (e.g. Torque teno virus 1-6, former genogroup 1) are less likely to be involved in the onset or modulation of diseases, while rarer isolates should be studied further in association with pathological conditions. Thus, analysis of genomic regions with phylogenetic resolution below the species level is important.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M (1997) A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241:92–97. https://doi.org/10.1006/bbrc.1997.7765
International Committee on Taxonomy of Viruses (2012) Virus taxonomy. Classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. Academic Press, London
Okamoto H, Takahashi M, Nishizawa T, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M (1999) Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology 259:428–436. https://doi.org/10.1006/viro.1999.9770
Leary TP, Erker JC, Chalmers ML, Desai SM, Mushahwar IK (1999) Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol 80(Pt 8):2115–2120
Hsiao K-L, Wang L-Y, Lin C-L, Liu H-F (2016) New phylogenetic groups of torque teno virus identified in Eastern Taiwan indigenes. PLoS One 11:1–10. https://doi.org/10.1371/journal.pone.0149901
Peng YH, Nishizawa T, Takahashi M, Ishikawa T, Yoshikawa A, Okamoto H (2002) Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Adv Virol 147:21–41
Mi Z, Yuan X, Pei G, Wang W, An X, Zhang Z, Huang Y, Peng F, Li S, Bai C, Tong Y (2014) High-throughput sequencing exclusively identified a novel Torque teno virus genotype in serum of a patient with fatal fever. Virol Sin 29:112–118. https://doi.org/10.1007/s12250-014-3424-z
Biagini P (2004) Human circoviruses. Vet Microbiol 98:95–101
International Committee on Taxonomy of Viruses—ICTV c (2009) Proposal: 2007.075a-xxV.v4.Anelloviridae.pdf. https://talk.ictvonline.org//taxonomy/p/taxonomy-history?taxnode_id=201852487. Accessed 20 Jan 2020
International Committee on Taxonomy of Viruses—ICTV c (2021) Proposal: 2020.015D. https://talk.ictvonline.org/taxonomy/p/taxonomy-history?taxnode_id=202009399. Accessed 26 Feb 2022
Hettmann A, Demcsák A, Bach Á, Decsi G, Dencs Á, Pálinkó D, Rovó L, Nagy K, Minarovits J, Takács M (2016) Detection and phylogenetic analysis of torque teno virus in salivary and tumor biopsy samples from head and neck carcinoma patients. Intervirology 59:123–129. https://doi.org/10.1159/000452974
Rocchi J, Ricci V, Albani M, Lanini L, Andreoli E, Macera L, Pistello M, Ceccherini-Nelli L, Bendinelli M, Maggi F (2009) Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9. Virology 394:235–242. https://doi.org/10.1016/j.virol.2009.08.036
Kincaid RP, Burke JM, Cox JC, de Villiers EM, Sullivan CS (2013) A human torque teno virus encodes a microRNA that inhibits interferon signaling. PLoS Pathog 9:e1003818. https://doi.org/10.1371/journal.ppat.1003818
Shulman LM, Davidson I (2017) Viruses with circular single-stranded DNA genomes are everywhere! Annu Rev Virol 4:159–180. https://doi.org/10.1146/annurev-virology-101416-041953
Rezahosseini O, Drabe CH, Sorensen SS, Rasmussen A, Perch M, Ostrowski SR, Nielsen SD (2019) Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation. Transplant Rev (Orlando) 33:137–144. https://doi.org/10.1016/j.trre.2019.03.004
Abbas AA, Diamond JM, Chehoud C, Chang B, Kotzin JJ, Young JC, Imai I, Haas AR, Cantu E, Lederer DJ, Meyer KC, Milewski RK, Olthoff KM, Shaked A, Christie JD, Bushman FD, Collman RG (2017) The perioperative lung transplant virome: torque teno viruses are elevated in donor lungs and show divergent dynamics in primary graft dysfunction. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 17:1313–1324. https://doi.org/10.1111/ajt.14076
Solis M, Velay A, Gantner P, Bausson J, Filipputtu A, Freitag R, Moulin B, Caillard S, Fafi-Kremer S (2019) Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect 79:56–60. https://doi.org/10.1016/j.jinf.2019.05.010
Honorato L, Witkin SS, Mendes-Correa MC, Conde Toscano ALC, Linhares IM, de Paula AV, Paião HGO, de Paula VS, Lopes AO, Lima SH, Raymundi VC, Ferreira NE, da Silva Junior AR, Abrahim KY, Braz-Silva PH, Tozetto-Mendoza TR (2022) The torque teno virus titer in saliva reflects the level of circulating CD4+ T lymphocytes and HIV in individuals undergoing antiretroviral maintenance therapy. Front Med. https://doi.org/10.3389/fmed.2021.809312
Forqué L, Albert E, Giménez E, Torres I, Carbonell N, Ferreres J, Blasco ML, Navarro D (2022) Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: may it help to predict clinical outcomes? J Clin Virol 148:105082. https://doi.org/10.1016/j.jcv.2022.105082
Spandole-Dinu S, Cimponeriu DG, Crăciun A-M, Radu I, Nica S, Toma M, Alexiu OA, Iorga CS, Berca L-M, Nica R (2018) Prevalence of human anelloviruses in Romanian healthy subjects and patients with common pathologies. BMC Infect Dis 18:334. https://doi.org/10.1186/s12879-018-3248-9
Spandole S, Cimponeriu D, Toma M, Radu I, Ion D (2013) Rapid detection of human torque teno viruses using high-resolution melting analysis. Balkan J Med Genet 16:55–62. https://doi.org/10.2478/bjmg-2013-0018
Cimponeriu D, Serafinceanu C, Apostol P, Toma M, Stavarachi M, Radu I, Craciun A, Spandole S, Nicolae P, Rusu L, Schiopu O, Ion D (2013) Potential association of obesity with IL6 G-174C polymorphism and TTV infections. Cent Eur J Biol 8:625–632. https://doi.org/10.2478/s11535-013-0178-1
Giacconi R, Maggi F, Macera L, Spezia PG, Pistello M, Provinciali M, Piacenza F, Basso A, Burkle A, Moreno-Villanueva M, Dolle MET, Jansen E, Grune T, Stuetz W, Gonos ES, Schon C, Bernhardt J, Grubeck-Loebenstein B, Sikora E, Dudkowska M, Janiszewska D, Toussaint O, Chainiaux FD, Franceschi C, Capri M, Hervonen A, Hurme M, Slagboom E, Breusing N (2019) Prevalence and loads of torquetenovirus (TTV) in the European MARK-AGE Study population. J Gerontol Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glz293
Magu SK, Kalghatgi AT, Bhagat MR (2015) Incidence and clinical implication of TT virus in patients with hepatitis and its frequency in blood donors in India. Med J Armed Forces India 71:340–344. https://doi.org/10.1016/j.mjafi.2015.06.023
Al-Qahtani AA, Alabsi ES, AbuOdeh R, Thalib L, Nasrallah GK (2016) Prevalence of anelloviruses (TTV, TTMDV, and TTMV) in healthy blood donors and in patients infected with HBV or HCV in Qatar. Virol J 13:208. https://doi.org/10.1186/s12985-016-0664-6
Li G, Zhou Z, Yao L, Xu Y, Wang L, Fan X (2019) Full annotation of serum virome in Chinese blood donors with elevated alanine aminotransferase levels. Transfusion 59:3177–3185. https://doi.org/10.1111/trf.15476
Najafimemar Z, Tabarraei A, Talei G, Moradi A (2018) Prevalence and genotyping of torque teno virus in HBV/HIV and chronic HBV patients in Iran. Iran Biomed J 22:338–344. https://doi.org/10.29252/ibj.22.5.338
Jelcic I, Hotz-Wagenblatt A, Hunziker A, Zur Hausen H, de Villiers EM (2004) Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin’s disease patient: genome reorganization and diversity in the hypervariable region. J Virol 78:7498–7507. https://doi.org/10.1128/JVI.78.14.7498-7507.2004
Devalle S, Niel C (2004) Distribution of TT virus genomic groups 1–5 in Brazilian blood donors, HBV carriers, and HIV-1-infected patients. J Med Virol 72:166–173. https://doi.org/10.1002/jmv.10564
Takacs M, Balog K, Toth G, Balogh Z, Szomor KN, Brojnas J, Rusvai E, Minarovits J, Berencsi G (2003) TT virus in Hungary: sequence heterogeneity and mixed infections. FEMS Immunol Med Microbiol 35:153–157
Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35:1547–1549. https://doi.org/10.1093/molbev/msy096
Erker JC, Leary TP, Desai SM, Chalmers ML, Mushahwar IK (1999) Analyses of TT virus full-length genomic sequences. J Gen Virol 80(Pt 7):1743–1750
Biagini P, Attoui H, Gallian P, Touinssi M, Cantaloube JF, de Micco P, de Lamballerie X (2000) Complete sequences of two highly divergent European isolates of TT virus. Biochem Biophys Res Commun 271:837–841. https://doi.org/10.1006/bbrc.2000.2721
Kakkola L, Tommiska J, Boele LC, Miettinen S, Blom T, Kekarainen T, Qiu J, Pintel D, Hoeben RC, Hedman K, Soderlund-Venermo M (2007) Construction and biological activity of a full-length molecular clone of human Torque teno virus (TTV) genotype 6. FEBS J 274:4719–4730. https://doi.org/10.1111/j.1742-4658.2007.06020.x
Lapa D, Del Porto P, Minosse C, D’Offizi G, Antinori A, Capobianchi MR, Visco-Comandini U, McPhee F, Garbuglia AR, Zaccarelli M (2021) Clinical relevance of torque teno virus (TTV) in HIV/HCV coinfected and HCV monoinfected patients treated with direct-acting antiviral therapy. J Clin Med 10:2092
Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M (1998) Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 10:1–16. https://doi.org/10.1016/S1386-6346(97)00123-X
Maggi F, Focosi D, Albani M, Lanini L, Vatteroni ML, Petrini M, Ceccherini-Nelli L, Pistello M, Bendinelli M (2010) Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia. J Virol 84:6891–6893. https://doi.org/10.1128/JVI.00273-10
Rosa AS, Araujo OC, Savassi-Ribas F, Fernandes CA, Coelho HS, Niel C, Villela-Nogueira CA, Araujo NM (2017) Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients. Virus Res 242:166–172. https://doi.org/10.1016/j.virusres.2017.09.022
Cancela F, Ramos N, Mirazo S, Mainardi V, Gerona S, Arbiza J (2016) Detection and molecular characterization of Torque Teno Virus (TTV) in Uruguay. Infect Genet Evol 44:501–506. https://doi.org/10.1016/j.meegid.2016.08.007
Haramoto E, Katayama H, Ohgaki S (2008) Quantification and genotyping of torque teno virus at a wastewater treatment plant in Japan. Appl Environ Microbiol 74:7434–7436. https://doi.org/10.1128/AEM.01605-08
Takemoto AY, Okubo P, Saito PK, Yamakawa RH, Watanabe MAE, da Silva V, Junior W, Borelli SD, Bedendo J (2015) Torque teno virus among dialysis and renal-transplant patients. Braz J Microbiol 46:307–311
Salakova M, Nemecek V, Konig J, Tachezy R (2004) Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic. BMC Infect Dis 4:56. https://doi.org/10.1186/1471-2334-4-56
Hassuna NA, Naguib E, Abdel-Fatah M, Mousa SMO (2017) Phylogenetic analysis of torque teno virus in thalassemic children in Egypt. Intervirology 60:102–108. https://doi.org/10.1159/000480507
Al-Mozaini MA, Al-Ahdal MN, Kessie G, Dela Cruz DM, Rezeig MA, Al-Shammary FJ (2006) Molecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients. Ann Saudi Med 26:444–449
Irshad MSS, Irshad K, Agarwal SK, Joshi YK (2008) Torque teno virus: its prevalence and isotypes in North India. World J Gastroenterol 14:6044–6051. https://doi.org/10.3748/wjg.14.6044
Tanaka Y, Mizokami M, Orito E, Ohno T, Nakano T, Kato T, Kato H, Mukaide M, Park YM, Kim BS, Ueda R (1998) New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett 437:201–206. https://doi.org/10.1016/S0014-5793(98)01231-9
Cetin Duran A, Kaya Cetinkaya O, Sayiner AA, Seydaoglu G, Ozkaratas E, Abacioglu H (2020) Changes on Hepatitis C virus genotype distribution in Western Turkey: evaluation of twelve-year data. Turk J Gastroenterol 31:128–135. https://doi.org/10.5152/tjg.2020.18798
Kate Grabowski M, Lessler J, Bazaale J, Nabukalu D, Nankinga J, Nantume B, Ssekasanvu J, Reynolds SJ, Ssekubugu R, Nalugoda F, Kigozi G, Kagaayi J, Santelli JS, Kennedy C, Wawer MJ, Serwadda D, Chang LW, Gray RH (2020) Migration, hotspots, and dispersal of HIV infection in Rakai, Uganda. Nat Commun 11:976. https://doi.org/10.1038/s41467-020-14636-y
Tyschik EA, Rasskazova AS, Degtyareva AV, Rebrikov DV, Sukhikh GT (2018) Torque teno virus dynamics during the first year of life. Virol J 15:96. https://doi.org/10.1186/s12985-018-1007-6
Kakkola L, Kaipio N, Hokynar K, Puolakkainen P, Mattila PS, Kokkola A, Partio EK, Eis-Hubinger AM, Soderlund-Venermo M, Hedman K (2004) Genoprevalence in human tissues of TT-virus genotype 6. Adv Virol 149:1095–1106. https://doi.org/10.1007/s00705-003-0290-7
Zheng H, Ye L, Fang X, Li B, Wang Y, Xiang X, Kong L, Wang W, Zeng Y, Wu Z, She Y, Zhou X (2007) Torque teno virus (SANBAN isolate) ORF2 protein suppresses NF-kappaB pathways via interaction with IkappaB kinases. J Virol 81:11917–11924. https://doi.org/10.1128/JVI.01101-07
Zhang H, Gao S, Lercher MJ, Hu S, Chen WH (2012) EvolView, an online tool for visualizing, annotating and managing phylogenetic trees. Nucleic Acids Res 40:W569-572. https://doi.org/10.1093/nar/gks576
Funding
This work was supported by a grant from the Romanian Ministry of Education and Research, CNCS - UEFISCDI, project number PN-III-P1-1.1-PD-2019-0496, within PNCDI III.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Oana Apircioaie, Larisa Gogianu, Lavinia Berca, Silvia Nica, and Mihai Toma. Sonia Spandole-Dinu, Dănuţ Cimponeriu, and Remus Nica designed the study. The first draft of the manuscript was written by Sonia Spandole-Dinu, and all authors commented on previous versions of the manuscript. Ileana Stoica supervised and critically revised the work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the National Institute of Research and Development for Food Bioresources Ethics Committee (342/16.05.2014). Consent forms for underage subjects were signed by legal guardians.
Additional information
Handling Editor: Zhongjie Shi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Spandole-Dinu, S., Cimponeriu, D., Stoica, I. et al. Phylogenetic analysis of torque teno virus in Romania: possible evidence of distinct geographical distribution. Arch Virol 167, 2311–2318 (2022). https://doi.org/10.1007/s00705-022-05559-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-022-05559-8